期刊文献+

阻塞性肝胆汁淤积下转录因子NR5A2和SP1、胆酸转运蛋白MRP3与肝脏损伤的相关性 被引量:7

Correlation of transcriptional factors NR5A2 and SP1,bile acids transporter MRP3 with liver injury in human obstructive cholestasis
原文传递
导出
摘要 目的研究阻塞性胆汁淤积下肝脏中转录因子NR5A2、SP1表达是否上调,以及其表达上调与胆酸转运蛋白MRP3基因的表达是否密切相关;MRP3表达上调是否具有减轻阻塞性胆汁淤积肝脏损伤的作用。方法收集阻塞性胆汁淤积组(胆结石或肝内胆管结石引起的黄疸患者手术切除的肝脏)和正常对照组(排除肝脏疾病的活检肝组织及肝转移癌无黄疸的患者肝脏)肝脏样品各15例。采用半定量PCR和免疫荧光方法检测NR5A2、SP1基因的表达,利用独立样品t检验和线性回归分析阻塞性胆汁淤积肝组织样品中MRP3 mRNA表达上调是否与NR5A2或SP1呈正相关,以及MRP3表达上调与反映肝脏损伤的指标ALT、AST是否存在负相关性。HE染色观察胆汁淤积组肝细胞坏死程度和MRP3蛋白表达高低的关系。结果阻塞性胆汁淤积肝脏中NR5A2和SP1 mRNA表达显著上调,其中NR5A2 mRNA增高3.7倍(P<0.01),SP1 mRNA上升3.2倍(P<0.01)。免疫荧光结果表明,阻塞性胆汁淤积组NR5A2和SP1蛋白表达也显著增加,NR5A2或SP1蛋白与胆酸转运蛋白MRP3 mRNA表达呈显著正相关(分别为r2=0.47,P<0.05和r2=0.51,P<0.01);MRP3蛋白表达与肝细胞坏死程度存在密切相关,并且MRP3蛋白表达量与ALT和AST均呈显著负相关(分别为r2=0.52,P<0.01和r2=0.39,P<0.05)。结论人阻塞性胆汁淤积下NR5A2和SP1表达上调,可诱导胆酸转运蛋白MRP3的表达,而MRP3表达上调可能有减轻肝脏损伤的作用。 Objective To determine the expression of transcriptional factors liver receptor homolog 1 (NR5A2) and specificity protein 1 (SP1) in obstructive cholestasis, explore their expression levels with that of multidrug resistance-associated protein 3 ( MRP3 ), and investigate the role of MRP3 in liver injury from the accumulation of toxic bile acids under cholestatic condition. Methods Live tissue samples from 15 patients with identified obstructive cholestasis and 15 control patients excluded liver diseases were collected. The expression of NR5A2 and SP1 was detected with RT-PCR and immunofluorescence staining. The correlation of the expression of MRP3 mRNA with the levels of NR5A2 and SP1, and with serum levels of ALT and AST were analyzed by liner regression. The correlation of the expression level of MRP3 protein and hepatic necrosis in human cholestasis (HE staining) was also studied. Results The expression levels of NR5A2 and SP1 were extremely increased in human cholestatie tissues, compared with normal controls (3.7-fold, P 〈 0. 01, and 3.2-fled, P 〈0.01, respectively). NR5A2 and SPI were predominately expressed in the nucleus of cholestatichepatocytes but not in that of normal controls. There was a significantly positive correlation of the expression levels of NRSA2 and SP1 proteins with hepatic MRP3 mRNA level in cholestatic tissues ( r2 = 0. 47, P 〈 0. 05, and r2 -0. 51, P 〈0. 01, respectively). HE staining also indicated that hepatic necrosis was more severe in the tissue samples with elevated expression of MRP3 protein under cholestatic condition. There was a markedly negative correlation between MRF3 protein expression and serum ALT and AST levels (r2 =0. 52, P 〈0. 01, and rE = 0. 39, P 〈 0. 05). Conclusion Hepatic NRSA2 and SP1 are upregulated in the liver tissue under cholestatic condition, which are positively correlated with the expression of MRP3. Meanwhile, the elevated MRP3 expres- sion may alleviate the liver injury caused by the accumulation of toxic bile acids under cholestatic condition.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第24期2474-2478,共5页 Journal of Third Military Medical University
基金 国家自然科学基金(30570842,81100280)~~
关键词 转录因子 NR5A2 SP1 MRP3 胆汁淤积 transcriptional factors NRSA2 SP1 MRP3 cholestasis
  • 相关文献

参考文献14

  • 1Hasegawa Y,Kishimoto S,Takahashi H,et al. Altered expression ofMRP2, MRP3 and UGT2B1 in the liver affects the disposition of mor-phine and its glucuronide conjugate in a rat model of cholestasis[ J]. JPharm Pharmacol, 2009,61(9) : 1205 -1210.
  • 2Teng S, Piquette-Miller M. Hepatoprotective role of PXR activationand MRP3 in cholic acid-induced cholestasis [ J]. Br J Pharmacol,2007,151(3): 367 -376.
  • 3Keppler D. Cholestasis and the role of basolateral efflux pumps [J]. ZGastroenterol, 2011,49(12) : 1553 -1557.
  • 4Schaap F G, van-der-Gaag N A, Gouma D J, ef al. High expression ofthe bile salt-homeostatic hormone fibroblast growth factor 19 in the liverof patients with extrahepatic cholestasis [ J]. Hepatology, 2009,49(4): 1228 -1235.
  • 5Bohan A, Chen W S, Denson L A, ef al. Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3 ( Abcc3) reduces liver inju-ry in obstructive cholestasis[ J]. J Biol Chem, 2003,278(38) : 36688-36698.
  • 6Zollner G, Fickert P, Silbert D,et al. Adaptive changes in hepatobili-ary transporter expression in primary biliary cirrhosis[ J]. J Hepatol,2003, 38(6) : 717 -727.
  • 7Donner M G,Warskulat U,Saha N, et al. Enhanced expression of ba-solateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liv-er by LPS[J]. Biol Chem, 2004, 385(3/4) : 331 -339.
  • 8Chai J,He Y, Cai S Y, et al. Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression inhuman obstructive cholestasis is mediated through tumor necrosis factoralpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway[ J]. Hepatology, 2012,55(5) : 1485 - 1494.
  • 9Chen W, Cai SY, Xu S, et al. Nuclear receptors RXHalpha: RARal-pha are repressors for human MRP3 expression[ J]. Am J Physiol Gas-trointest Liver Physiol, 2007, 292(5) : G1221 -G1227.
  • 10Jigorel E, Le-Vee M, Boursier-Neyret C, et al. Differential regulationof sinusoidal and canalicular hepatic drug transporter expression by xe-nobiotics activating drug-sensing receptors in primary human hepato-cytes[ J]. Drug Metab Dispos, 2006, 34( 10) : 1756 - 1763.

二级参考文献30

  • 1李琼,陈文生,罗东林,肖天利,房殿春.阻塞性胆汁淤积大鼠肝细胞膜蛋白MRP3与核受体RXRα蛋白表达关系的研究[J].第三军医大学学报,2006,28(12):1298-1301. 被引量:8
  • 2Seheffer G L, Kool M, de-Haas M, et al. Tissue distribution and induction of human muhidrug resistant protein 3 [ J]. Lab Invest, 2002, 82(2) : 193 -201.
  • 3Akita H, Suzuki H, Hirohashi T, et al. Transport activity of human MRP3 expressed in St9 cells: comparative studies with rat MRP3 [ J ]. Pharm Res, 2002, 19(1) : 34 -41.
  • 4Rau S, Autschbach F, Riedel H D, et al. Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas[J]. Eur J Clin Invest, 2008, 38(2): 134 -142.
  • 5Hasegawa Y, Kishimoto S, Takahashi H, et al. Altered expression of MRP2, MRP3 and UGT2B1 in the liver affects the disposition of morphine and its glucuronide conjugate in a rat model of cbolestasis[J]. J Pharm Pharmacol, 2009, 61 (9) : 1205 - 1210.
  • 6Csanaky I L, Aleksunes L M, Tanaka Y, et al. Role of hepatic transporters in prevention of biie acid toxicity after partial hepatectomy in mice [ J ]. Am J Physiol Gastrointest Liver Physiol, 2009, 297 ( 3 ) : G419 - G433.
  • 7Liu Y H, Di Y M, Zhou Z W, et al. Muhidrug resistance-associated proteins and implications in drug development[J]. Clin Exp Pharmacol Physiol, 2010, 37(1): 115-120.
  • 8Csanaky I L, Aleksunes L M, Tanaka Y, et al. Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice [ J ]. Am J Physiol Gastrointest Liver Physiol, 2009, 297 ( 3 ) : G419 - G433.
  • 9Bohan A, Chen W S, Denson L A, et al. Tumor necrosis factor alphadependent up-regulation of Lrh-1 and Mrp3 ( Abcc3 ) reduces liver injury in obstructive choldstasis [ J ]. J Biol Chem, 2003, 278 ( 38 ) : 36688 - 36698.
  • 10Wagner M, Halilbasic E, Marschall H U, et al. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice[ J]. Hepatology, 2005, 42 (2) : 420 - 430.

共引文献11

同被引文献82

  • 1杨慧玲,刘建全.9种“藏茵陈”原植物中的7种有效化学成分研究[J].中草药,2005,36(8):1233-1237. 被引量:28
  • 2Stieger B,Meier Y,Meier P J.The bile salt export pump [J].Pflugers Arch,2007,453(5):611-620.
  • 3Soroka C J,Boyer J L.Biosythesis and trafficking of the bile salt export pump,Bsep:Therapeutic implications of Bsep mutations [J].Mol Aspects Med,2013,pii:S0098-2997(13)00034-4.[Epub ahead of print].
  • 4dada M,Canals D,Hannun Y A,et al.Sphingolipid regulation of ezrin,radixin,and moesin proteins family:Implications for cell dy-namics[J].Biochim Biophys Acta,2014,1841(5):727-737.
  • 5Kmbitz R,Droge C,Stindt J,et at.The bile salt export pump(Bsep)in health and disease[J].Clin Res Hepatol Gastroenterol,2012,36(6):536-553.
  • 6Neisch A L,Fehon R G.Ezrin,Radixin and Moesin:key regulators of membrane-cortex interactions and signaling [J].Curr Opin Cell Biol,2011,23(4):377-382.
  • 7Niggli V,Rossy J.Ezrin/radixin/moesin:versatile controllers of signa-ling molecules and of the cortical cytoskeleton [J].Int J Biochem Cell Biol,2008,40(3):344-349.
  • 8Maniti O,Carvalho K,Picart C.Model membranes to shed light on the biochemical and physical properties of ezrin/radixin/moesin [J].Bio-chimie,2013,95(1):3-11.
  • 9Kikuchi S,Hata M,Fukumoto K,et al.Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes [J].Nat Genet,2002,31(3):320-325.
  • 10Fukumoto K,Kikuchi S,Itoh N,et al.Effects of genetic back-grounds on hyperbilirubinemia in radixin-deficient mice due to differ-ent expression levels of Mrp3 [J].Biochim Biophys Acta,2007,1172(3):298-306.

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部